Skip to main content
. 2021 Dec 7;8:1565–1577. doi: 10.2147/JHC.S335879

Figure 2.

Figure 2

Comparisons of OS between patients initially treated with TARE and TACE in (A) the entire study population (n = 138), (B) patients without lymph node and distant metastases (n = 123), (C) patients whose BCLC stage at diagnosis was stage B or C (n = 103), and (D) patients with tumor diameter ≥5 cm before the first treatment (n = 110).

Abbreviations: BCLC, Barcelona Clinic Liver Cancer; TACE, trans-arterial chemoembolization; OS, overall survival; TARE, trans-arterial radioembolization.